- Short report
- Open Access
Blastocystis sp. in splenic cysts: causative agent or accidental association? A unique case report
© Santos et al.; licensee BioMed Central Ltd. 2014
- Received: 25 January 2014
- Accepted: 16 April 2014
- Published: 29 April 2014
Blastocystis sp. is one of the most prevalent parasites found in human stool and has been recently considered an opportunistic emerging pathogen in immunocompromised individuals. However, cases of invasive intestinal infections and skin rashes have been attributed to infection by Blastocystis sp in immunocompetent individuals, suggesting that it is an emerging parasite with pathogenic potential.
We present a case of a 22 year old female patient who complained of pain in the left hypochondrium. Ultrasonography and abdominal computed tomography scans showed two splenic cysts. The cyst fluid analysis demonstrated numerous Blastocystis sp.; PCR and DNA sequencing analyses confirmed the presence of Blastocystis subtype 3.
This is, to our knowledge, the first case report of the presence of Blastocystis subtype 3 in extra-intestinal organs and is strong evidence that Blastocystis sp. is potentially pathogenic and invasive. However, further studies are required to determine the pathogenicity of the parasite.
- Blastocystis spp
- Immunocompetent individual
- Splenic cyst
Blastocystis spp. are parasites of the intestinal tract found in many hosts including humans . This pathogen is commonly found in apparently healthy and asymptomatic individuals and in patients with gastrointestinal disease. Its pathogenicity has been reported in the literature in immunocompromised pediatric, cancer, and HIV-infected patients [2–5], however, the clinical relevance of Blastocystis sp. in immunocompetent individuals remains unclear. The association between Blastocystis sp. and arthritis, dermatological disorders, and irritable bowel syndrome [6–8] have also been reported. In addition, its invasive potential has been suggested in animal models [9, 10] and in humans [11–13]. Recently, cases of enteroinvasion by Blastocystis sp were shown in vivo through endoscopy and biopsy analyses . In this case report, Blastocystis sp. was detected in ulcers in the cecum, transverse colon, and rectum of an immunocompetent patient.
Blastocystis has been traditionally named Blastocystis hominis when isolated from human fecal materials. However, recent phylogenetic analyses suggest limiting its name to “Blastocystis sp ecies” because of their genetic diversity. This parasite has been considered as a species complex comprising 13 subtypes, of which at least nine have been found in humans . Furthermore, they exhibit wide genetic diversity that is sufficient to assign them to different species . The confirmation of their species status and determination of virulence and pathogenic profiles might explain why some patients are asymptomatic while others present clinical symptoms .
Blastocystis spp. was discovered over a century ago, however, many issues regarding its infection still remain unanswered. Accumulating evidence reinforces the pathogenic potential of Blastocystis sp. in immunocompetent individuals [6–8]; however, systematic studies characterizing different clinical isolates of Blastocystis subtypes and new diagnostic approaches are needed to improve our understanding about these cases. This is the first case report describing the presence of Blastocystis sp. in the fluid of splenic cysts. According to our observation, the following question is raised: ‘Can Blastocystis be the culprit for the formation of splenic cysts or is this association based on other reasons?’
Splenic cysts constitute very rare clinical entities. They may occur secondary to trauma or parasitic infestations, particularly by Echinococcus granulosus[18, 19]. Cases of isolated splenic involvement in hydatid disease are not very frequent even in endemic regions . Interestingly, this report describes the presence of Blastocystis subtype 3 in splenic cysts, a parasite mostly found in human stool. A previous case study described Blastocystis present in the liver abscess aspirate of a patient with history of fever, watery diarrhea and high Anti-Entamoeba histolytica antibody titer . Although the pathogenic mechanisms are unclear; we speculate that two hypotheses could be considered to explain how the Blastocystis sp got into the spleen. First, Blastocystis sp might penetrate and invade the intestinal mucosa and submucosa causing ulcers, and progress through the blood and/or lymphatic system and migrate to the spleen. Second, the parasite might gain access to extra-intestinal sites with the help of coinfections or other pathological circumstances. To complement these hypotheses, Blastocystis sp have to survive during infection, essentially by responding rapidly to changes in the microenvironment in intestine, blood and escaping host defense mechanisms. There are few studies addressing the mechanism of pathogenesis, regarding cellular microbiology, immune evasion, and life cycle of Blastocystis sp. This parasite one of the most difficult organisms to identify in stool samples because of their morphological biodiversity; some of the commonly reported forms in culture or in fecal specimens are vacuolar, granular or amoeboid. However, other forms that might occur with relative frequency might be missed by untrained examiners . Conversely, the lack of standardized diagnosis may also lead to misinterpretation of results . Recently, a study revealed poor agreement in reporting Blastocystis sp. positive specimens when comparing the diagnostic performance of various European reference laboratories . Several molecular epidemiological studies suggest a possible correlation between subtypes and clinical presentations of Blastocystis infections. Other studies observed no association between presence of this organism and disease [21, 22]. These discrepant results might be explained by subtypes with differences in virulence, or by low sensitivity in the diagnosis techniques used. This scenario is strikingly similar to that of an erroneous diagnosis of Entamoeba histolytica. For many years, the virulence and pathogenicity of E. histolytica was questioned until molecular techniques irrefutably showed that there are two genetically distinct, but morphologically identical, species in what was formerly known as E. histolytica. Differences in the pathogenesis of E. histolytica and E. dispar also helped explain the epidemiology, presentation of symptoms, and pathology of amoebiasis .
Currently, there is not enough evidence showing that Blastocystis sp. is a nonpathogenic organism and its association with gastrointestinal diseases raises questions about its pathogenicity [5–8]. Moreover, there are accumulating data suggesting its pathogenic potential in immunocompetent individuals [1, 12–14].
The genome of Blastocystis subtype 7 encodes proteases, hexose digestion enzymes, lectins, protease inhibitors, and glycosyltransferases besides several proteins that are predicted to be secreted . The roles of some of these proteins are known in other parasites  with direct connections to their pathogenicity in processes such as host cell invasion, excystation, metabolism, cytoadherence, and other virulence functions . Thus, proteomics and transcriptomic analyses will be useful in order to show whether these predicted proteins have any role in the pathogenesis of Blastocystis.
Protease activity has been described in Blastocystis spp. isolated from symptomatic patients [26–28]. In addition, other studies have demonstrated that cysteine proteases from Blastocystis can increase epithelial permeability by modulating the tight junction complex , induce pro-inflammatory cytokine interleukin-8 (IL-8) , and degrade human immunoglobulin A (IgA) . Cysteine proteases are important enzymes for host invasion and infection and are well recognized as virulence factors in pathogenic protozoa .
In this study, Blastocystis subtype 3 was detected in splenic cysts. The literature on the molecular analysis of human Blastocystis isolates suggests that they are mostly of genotype subtype 3. Genotype variability has been reported to play an influential role in the pathogenicity of Blastocystis[32, 33]. However, previous studies have associated subtypes 1, 4, and 7 with human pathology, whereas subtypes 2 and 3 predominate among healthy carriers . Infections with mixed subtypes, and the high degree of genetic diversity among subtypes, obscure possible correlations between pathogenicity and Blastocystis subtypes [5, 34, 35].
To our knowledge, this is the first report describing Blastocystis subtype 3 in an extra-intestinal organ. We have no knowledge as to how the parasite gained access to the spleen. The answer to this question will deepen our understanding about the pathogenicity of Blastocystis sp. Its pathogenic potential is a relevant threat to immunocompetent individuals and this report emphasizes the importance of an increased awareness and recognition of this pathogen.
Written informed consent was obtained from the patient for publication of this Case report. A copy of the written consent is available for review by the Editor of this journal.
This work was financed by PAPES-VI/FIOCRUZ. The funders had no participation in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Scanlan PD: Blastocystis: past pitfalls and future perspectives. Trends Parasitol. 2012, 28: 327-334. 10.1016/j.pt.2012.05.001.View ArticlePubMedGoogle Scholar
- Noureldin MS, Shaltout AA, El Hamshary EM, Ali ME: Opportunistic intestinal protozoa linfections in immunocompromised children. J Egypt Soc Parasitol. 1999, 29: 951-961.PubMedGoogle Scholar
- Tasova Y, Sahin B, Koltas S, Paydas S: Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama. 2000, 54: 133-136.PubMedGoogle Scholar
- Kurniawan A, Karyadi T, Dwintasari SW, Sari IP, Yunihastuti E, Djauzi S, Smith HV: Intestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia. Trans R Soc Trop Med Hyg. 2009, 103: 892-898. 10.1016/j.trstmh.2009.02.017.View ArticlePubMedGoogle Scholar
- Mirza H, Tan KSW: Clinical aspects of Blastocystis infections: advancements amidst controversies. Parasitology Res Monog. 2012, 4: 65-84. 10.1007/978-3-642-32738-4_5.View ArticleGoogle Scholar
- Valsecchi R, Leghissa P, Greco V: Cutaneous lesions in Blastocystis homini s infection. Acta Derm Venereol. 2004, 84: 322-332. 10.1080/00015550410025949.View ArticlePubMedGoogle Scholar
- Verma R, Delfanian K: Blastocystis hominis associated acute urticaria. Am J Med Sci. 2013, 346: 80-81. 10.1097/MAJ.0b013e3182801478.View ArticlePubMedGoogle Scholar
- Poirier P, Wawrzyniak I, Vivarès CP, Delbac F, El Alaoui H: New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog. 2012, 8: e1002545-10.1371/journal.ppat.1002545.PubMed CentralView ArticlePubMedGoogle Scholar
- Hussein EM, Hussein AM, Eida MM, Atwa MM: Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008, 102: 853-860. 10.1007/s00436-007-0833-z.View ArticlePubMedGoogle Scholar
- Elwakil HS, Hewedi IH: Pathogenic potential of Blastocystishominis in laboratory mice. Parasitol Res. 2010, 107: 685-689. 10.1007/s00436-010-1922-y.View ArticlePubMedGoogle Scholar
- Hu KC, Lin CC, Wang TE, Liu CY, Chen MJ, Chang WH: Amoebic liver abscess or is it?. Gut. 2008, 57: 683-View ArticleGoogle Scholar
- Patino WD, Cavuoti D, Banerjee SK, Swartz K, Ashfaq R, Gokaslan T: Cytologic diagnosis of Blastocystis hominis in peritoneal fluid: a case report. Acta Cytol. 2008, 52: 718-720. 10.1159/000325628.View ArticlePubMedGoogle Scholar
- Janarthanan S, Khoury N, Antak F: An unusual case of invasive Blastocystishominis infection. Endoscopy. 2011, 43: E185-E186. 10.1055/s-0030-1256322.View ArticlePubMedGoogle Scholar
- Tan KS, Mirza H, Teo JD, Wu B, Macary PA: Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep. 2010, 12: 28-35. 10.1007/s11908-009-0073-8.View ArticlePubMedGoogle Scholar
- Parkar U, Traub RJ, Vitali S, Elliot A, Levecke B, Robertson I, Geurden T, Steele J, Drake J, Thompson RC: Molecular characterization of Blastocystis isolates from zooanimals and their animal-keepers. Vet Parasitol. 2010, 19: 8-17.View ArticleGoogle Scholar
- Parija SC, Jeremiah SS: Blastocystis: taxonomy, biology and virulence. Trop Parasitol. 2013, 3: 7-25. 10.4103/2229-5070.113888.View ArticleGoogle Scholar
- Stensvold CR, Arendrup MC, Jespersgaard C, Molbak K, Nielsen HV: Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis. 2007, 59: 303-307. 10.1016/j.diagmicrobio.2007.06.003.View ArticlePubMedGoogle Scholar
- Adas G, Oguzhan KO, Altiok M, Battal M, Bender O, Ozcan D, Karahan S: Diagnostic problems with parasitic and non-parasitic splenic cysts. BMC Surg. 2009, 9: 9-12. 10.1186/1471-2482-9-9.PubMed CentralView ArticlePubMedGoogle Scholar
- Pukar MM, Pukar SM: Giant solitary hydatid cyst of spleen–a case report. Int J Surg Case Rep. 2013, 4: 435-437. 10.1016/j.ijscr.2012.12.019.PubMed CentralView ArticlePubMedGoogle Scholar
- Utzinger J, Botero-Kleiven S, Castelli F, Chiodini PL, Edwards H, Köhler N, Gulletta M, Lebbad M, Manser M, Matthys B, N’Goran EK, Tannich E, Vounatsou P, Marti H: Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories. Clin Microbiol Infect. 2010, 16: 267-273. 10.1111/j.1469-0691.2009.02782.x.View ArticlePubMedGoogle Scholar
- Leder K, Hellard ME, Sinclair MI, Fairley CK, Wolfe R: No correlation between clinical symptoms and Blastocystis hominis in immunocompetent individuals. J Gastroenterol Hepatol. 2005, 20: 1390-1394. 10.1111/j.1440-1746.2005.03868.x.View ArticlePubMedGoogle Scholar
- Kuo HY, Chiang DH, Wang CC, Chen TL, Fung CP, Lin CP, Cho WL, Liu CY: Clinical significance of Blastocystis hominis: experience from a medical center in northern Taiwan. J Microbiol Immunol Infect. 2008, 41: 222-226.PubMedGoogle Scholar
- Stanley SM: Amoebiasis. Lancet. 2003, 361: 1025-1034. 10.1016/S0140-6736(03)12830-9.View ArticlePubMedGoogle Scholar
- Denoeud F, Roussel M, Noel B, Wawrzyniak I, Da Silva C, Diogon M, Viscogliosi E, Brochier-Armanet C, Couloux A, Poulain J, Segurens B, Anthouard V, Texier C, Blot N, Poirier P, Ng GC, Tan KS, Artiguenave F, Jaillon O, Aury JM, Delbac F, Wincker P, Vivarès CP, El Alaoui H: Genome sequence of the stramen opile Blastocystis, a human anaerobic parasite. Genome Biol. 2011, 12: R29-10.1186/gb-2011-12-3-r29.PubMed CentralView ArticlePubMedGoogle Scholar
- Scalan PD, Stensvols CR: Blastocystis: getting to grips with our guileful guest. Trends Parasitol. 2013, 29: 523-529. 10.1016/j.pt.2013.08.006.View ArticleGoogle Scholar
- Mirza H, Tan KS: Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol Res. 2009, 104: 355-361. 10.1007/s00436-008-1203-1.View ArticlePubMedGoogle Scholar
- Chandramathi S, Suresh K, Anita ZB, Kuppusamy UR: Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic?. Trans R Soc Trop Med Hyg. 2012, 106: 267-269. 10.1016/j.trstmh.2011.12.008.View ArticlePubMedGoogle Scholar
- Rajamanikam A, Govind SK: Amoebic forms of Blastocystis spp.–evidence for a pathogenic role. Parasit Vectors. 2013, 6: 295-304. 10.1186/1756-3305-6-295.PubMed CentralView ArticlePubMedGoogle Scholar
- Mirza H, Wu Z, Teo JD, Tan KS: Statin-pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases. Cell Microbiol. 2012, 14: 1474-1484. 10.1111/j.1462-5822.2012.01814.x.View ArticlePubMedGoogle Scholar
- Puthia MK, Lu J, Tan KS: Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kB-dependent manner. Eukaryot Cell. 2008, 7: 435-443. 10.1128/EC.00371-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Puthia MK, Vaithilingam A, Lu J, Tan KS: Degradation of human secretory immunoglobulin A by Blastocystis. Parasitol Res. 2005, 97: 386-389. 10.1007/s00436-005-1461-0.View ArticlePubMedGoogle Scholar
- Souppart L, Sanciu G, Cian A, Wawrzyniak I, Delbac F, Capron M, Dei-Cas E, Boorom K, Delhaes L, Viscogliosi E: Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res. 2009, 105: 413-421. 10.1007/s00436-009-1398-9.View ArticlePubMedGoogle Scholar
- Kumarasamy V, Roslani AC, Rani KU, Govind SK: Advantage of using colonic washouts for Blastocystis detection in colorectal cancer patients. Parasit Vectors. 2014, 7: 162-166. 10.1186/1756-3305-7-162.PubMed CentralView ArticlePubMedGoogle Scholar
- Dogruman-Al F, Dagci H, Yoshikawa H, Kurt O, Demirel M: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res. 2008, 103: 685-689. 10.1007/s00436-008-1031-3.View ArticlePubMedGoogle Scholar
- Roberts TD, Stark D, Harkness J, Ellis J: Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis. Eur J Clin Microbiol Infect Dis. 2013, 32: 335-343. 10.1007/s10096-012-1746-z.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.